You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 300 No. 12, September 24, 2008 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Letters
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Related article
 •Related letter
 •Similar articles in JAMA
 Topic Collections
 •Oncology
 •Colon Cancer
 •Radiation Therapy
 •Prognosis/ Outcomes
 •Drug Therapy
 •Drug Therapy, Other
 •Gastroenterology
 •Gastrointestinal Diseases
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Chemotherapy and Radiotherapy for Anal Canal Carcinoma

Since this article does not have an abstract, we have provided the first 125 words of the full text and any section headings.

To the Editor: Dr Ajani and colleagues1 compared a combination of fluorouracil, mitomycin, and radiotherapy vs fluorouracil, cisplatin, and radiotherapy for the treatment of anal canal carcinoma. The 2 study groups had similar levels of toxicity, and the adherence to both chemotherapy and radiotherapy was comparable. However, there were some differences in treatment results.

One possible explanation for the significantly better time to colostomy in the standard treatment group is not linked to the chemotherapy itself, but rather to the immediate starting of radiotherapy. In the experimental group, radiation was delayed for almost 2 months. The importance of immediate combined treatment has been shown for laryngeal cancer2 and may also be true for anal carcinoma, which is especially sensitive to radiotherapy.3

Financial Disclosures: None reported.

Daniela Musio, MD; Giovanni Codacci-Pisanelli, MD
oncologialatina@uniroma1.it
Department of Experimental Medicine
Università La Sapienza
Rome, Italy

1. Ajani JA, Winter KA, Leonard L; et al. Fluorouracil, mitomycin, and radiotherapy vs fluorouracil, cisplatin, and radiotherapy for carcinoma of the anal canal: a randomized controlled trial. JAMA. 2008;299(16):1914-1921. FREE FULL TEXT
2. Forastiere AA, Goepfert H, Maor M; et al. Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med. 2003;349(22):2091-2098. FREE FULL TEXT
3. Martenson JA Jr, Gunderson LL. External radiation therapy without chemotherapy in the management of anal cancer. Cancer. 1993;71(5):1736-1740. FULL TEXT | WEB OF SCIENCE | PUBMED

Letters Section Editor: Robert M.Golub, MD, Senior Editor.

JAMA. 2008;300(12):1410-1411.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLE

Fluorouracil, Mitomycin, and Radiotherapy vs Fluorouracil, Cisplatin, and Radiotherapy for Carcinoma of the Anal Canal: A Randomized Controlled Trial
Jaffer A. Ajani, Kathryn A. Winter, Leonard L. Gunderson, John Pedersen, Al B. Benson, III, Charles R. Thomas, Jr, Robert J. Mayer, Michael G. Haddock, Tyvin A. Rich, and Christopher Willett
JAMA. 2008;299(16):1914-1921.
ABSTRACT | FULL TEXT  

RELATED LETTER

Chemotherapy and Radiotherapy for Anal Canal Carcinoma—Reply
Jaffer A. Ajani, Kathryn A. Winter, and Leonard L. Gunderson
JAMA. 2008;300(12):1411.
EXTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2008 American Medical Association. All Rights Reserved.